- Lobbying
- pharmaceutical AND research AND and AND manufacturers AND of AND america AND phrma
Lobbying Arrangements Results for 'Pharmaceutical Research And Manufacturers Of America Phrma'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Independent Patient Advisory Board (IPAB) and Medicare Part D |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
G. Fox Consulting | |||
Details Any federal issues regarding the research and development of pharmaceuticals |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Dentons US LLP | |||
Details Medicare, Medicaid, PDUFA and Patent Reform |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Mr. Derrick White | |||
Details Healthcare issues |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Wheat Government Relations | |||
Details Health care reform, in particular biosimilars. |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Ms. Rebecca Halkias | |||
Details Trade Policy in Latin America |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
FTI Government Affairs | |||
Details Health care reform issues affecting the pharmaceutical industry. |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
PRICEWATERHOUSECOOPERS | |||
Details Ensuring adequate and effective intellectual property rights for pharmaceutical products in non-U.S. markets. |
The Pharmaceutical Research and Manufacturers of America (PhRMA)
|
CROWELL & MORING LLP | |||
Details Medicare Part D, Prescription Drug Program |
Pharmaceutical Research and Manufacturers of America
|
Prime Policy Group | |||
Details Issues related to The Patient Protection and Affordable Care Act (Public Law 111 148) |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
WHITMER & WORRALL, LLC | |||
Details Medicaid & Medicare COVID-19 Research and development of biopharmaceuticals Economic impact of the biopharmaceutical industry Research and development of biopharmaceuticals Inflation Reduction Act |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
KLINK CAMPAIGNS, INC | |||
Details HR 9 and any other legislation regarding patent law reform. |
Pharmaceutical Research and Manufactureres of America (PhRMA)
|
MCKENNA, LONG & ALDRIDGE | |||
Details Monitoring healthcare and drug pricing discussions, including implementation of the Inflation Reduction Act of 2022, H.R.5376, P.L.117-169. Issues related to policies concerning the pharmaceutical ... |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
The Simmons & Russell Group, LLC | |||
Details FY17 Appropriations Bills |
Pharmaceutical Research and Manufacturers of America
Pharmaceutical association. |
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | |||
Details FY 2024 Appropriations bills |
SL Strategies, LLC (On behalf of PhRMA)
|
LKB STRATEGIES LLC | |||
Details water quality legislation, S.1005 patent law, S.515, H.R. 1260 |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
THE ACCORD GROUP | |||
Details Implementation of the Patient Protection and Affordable Care Act; Issues related to government efforts to roll out the COVID vaccination system. Discussions surrounding pending tax related provisio... |
PhRMA (on behalf of We Work for Health)
|
Capitol Legislative Strategies LLC | |||
Details Issues related to international trade; nominations to USTR and Commerce Issues related to intellectual property |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
TIGER HILL PARTNERS LLC | |||
Details WTO negotiations, free trade agreements, bilateral WTO accession agreements and other bilateral negotiations of interest to the research-based pharmaceutical industry. |
Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmaceutical research and biotechnology company trade association |
Preston Gates Ellis & Rouvelas Meeds LLP | |||
Details Education regarding market based solutions to bring down the cost of drug prices. Education regarding the dangers of global counterfeit medications. Education regarding the Part D program. Educatio... |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Advanced Policy Consulting, LLC | |||
Details Issues related to patient access and pricing. Issues related to policy changes to Medicare Part D. Issues related to PBM reform; H.R. 2880, Protecting Patients Against PBM Abuses Act and H.R.5376, ... |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Desimone Consulting, LLC | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169). Issues related to the 340b program. |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Tiber Creek Health Strategies, Inc. | |||
Details Issues related to various healthcare reform and drug pricing. |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues relating to drug pricing, value and transparency, generally. Issues relating to medical research and development, as well as access to medicines Issues related to Medicare Parts B and D, inc... |
PhRMA (Pharmaceutical Research & Manufacturers of America)
|
Roberti Global (f/k/a Roberti White, LLC) | |||
Details Trans-Pacific Partnership |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Hogan Lovells US LLP | |||
Details H.R. 1249, Leahy-Smith America Invents Act, relating to patent reform Issues relating to 340B Drug Pricing Program |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Elmendorf Ryan | |||
Details Legislative monitoring of prescription drug issues |
Pharmaceutical Research and Manufacturers of America (PhRMA)
Represents the countrys leading pharmaceutical research and biotechnology companies |
The Glover Park Group LLC | |||
Details FY23 Consolidated Appropriations & FY23 NDAA FY23 Consolidated Appropriations FY23 NDAA |
Pharmaceutical Researchers and Manufacturers of America (PhRMA)
|
Cassidy & Associates, Inc. | |||
Details Issues related to the Patient Protection and Affordable Care Act, P.L. 111-148: Medicare funding issues, and the American Taxpayer Relief Act of 2012, P.L. 112-240. Issues related to Protecting Sen... |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
The Ingram Group LLC DBA The FIRST Group | |||
Details general health care, medical care and pharmaceutical issues |
Pharmaceutical Research and Manufacturers of America (PhRMA)
trade association acting on behalf of brand name drug manufacturers |
Breaux Lott Leadership Group | |||
Details Legislative issues related to access to pharmaceuticals, including H.R. 3 Lower Drug Costs Now, S. 102 Prescriptions Drug Price Relief Act of 2019, and FY22 Agriculture Appropriations |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
S-3 Group | |||
Details FY23 Consolidated Appropriations & FY23 NDAA |
Pharmaceutical Research and Manufacturers of America (PhRMA)
Trade organization for pharmaceutical research and manufacturers |
Cassidy & Associates, Inc. | |||
Details Monitoring healthcare legislation. Education regarding market based solutions to bring down the cost of drug prices. Education regarding the dangers of global counterfeit medications. Education reg... |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Advanced Policy Consulting, LLC | |||
Details General provisions related to the pharmaceutical industry including prescription drug affordability and access, intellectual property, privacy, 340B drug discount program policy, and clinical trial... |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
OGR (formerly known as Ogilvy Government Relations) | |||
Details Legislative issues related to access to pharmaceuticals; Rebates in Medicaid and for dual-eligibles; Medicaid coverage issues; 340B Drug Program; Medicare Part B and D prescription drug reimburseme... |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Capitol Counsel LLC | |||
Details General education about policies impacting pharmaceutical development, approval and reimbursement; Non-interference. Rebates for Medicare Part D. Importation. 340B Program. IPI drug pricing propos... |
PhRMA
|
Williams and Jensen, PLLC |